← Top stories
Expansion▲ Bullish for Morepen Laboratories
Morepen files first US drug application, eyes generic diabetes market
The brief
- Morepen filed its first US drug application, targeting the generic diabetes market
- US approval could open a new market for Morepen, though the report gives no timing or sales estimates